The double soul of BMG Pharma and our future challenges
Some of the main newspapers have shared important statements from our CEO Marco Mastrodonato.
Caltalks' interview with our CEO
An Italian excellence at the service of the biotechnology sector
A business plan focused on commercial expansion, research and development. In two years, the company has created 4 new patents and registered 36 innovative products, as well as launching 37 of them on the international scene.
Massimo Doris, CEO of Banca Mediolanum buys 2% of the share package, creating a partnership with the company specializing in the production of new biomaterials derived from hyaluronic acid.